close 74% of retail investor accounts lose money when trading CFDs with this provider. Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
SearchSearch
Change languageEnglish (International)
Dashboard

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

Home・Stock List・Seres Therapeutics Inc
Search

Seres Therapeutics Inc

Closed

SectorHealthcare

8.69 0.58

Buy

Price update 25 Feb 2026, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

8.36

Max

8.86

Key metrics

By Trading Economics

Income

28M

8.2M

Sales

351K

351K

P/E

Sector Avg

9.273

108.767

EPS

0.94

Profit margin

2,337.322

Employees

103

EBITDA

28M

9.3M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+142.77% upside

Dividends

By Dow Jones

Next Earnings

12 Mar 2026

Market Stats

By TradingEconomics

Market Cap

-60M

74M

Previous open

8.11

Previous close

8.69

News Sentiment

By Acuity

59%

41%

306 / 351 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

N/A / 9.31 Support & Resistance

Seres Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

12 Feb 2026, 13:08 UTC

Major Market Movers

Seres Shares Down After Co Pauses Drug Development, Lays Off Workers

DJ

Read

Peer Comparison

Price change

Seres Therapeutics Inc Forecast

Price Target

By TipRanks

142.77% upside

12 Months Forecast

Average 21 USD  142.77%

High 22 USD

Low 20 USD

Based on 2 Wall Street analysts offering 12 month price targets forSeres Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Based on 2 analysts giving stock ratings to Seres Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 9.31Support & Resistance

Short Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

306 / 351 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,028

↓-1.37%

JNJ

Johnson and Johnson

245.17

↓-0.42%

ABBV

AbbVie Inc

226.93

↓-0.59%

NVS

Novartis AG

166.41

↓-0.16%

MRK

Merck & Co Inc.

122.41

↓-1.23%
help-icon Live chat